Standard Chemical & Pharmaceutical Co Ltd (1720) — Cash Flow Reinvestment Rate
Standard Chemical & Pharmaceutical Co Ltd (1720) has a Cash Flow Reinvestment Rate of 0.38x as of September 2025, reinvesting NT$193.82 Million (capex NT$78.71 Million plus investments NT$-115.11 Million) from operating cash flow of NT$510.55 Million. Explore capital reinvestment ratio of Standard Chemical & Pharmaceutical Co Lt to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Standard Chemical & Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2002–2024)
Historical reinvestment intensity for Standard Chemical & Pharmaceutical Co Ltd across 23 annual periods. Also explore 1720 current and non-current assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Standard Chemical & Pharmaceutical Co Ltd (2002–2024)
Year-by-year capital reinvestment analysis for Standard Chemical & Pharmaceutical Co Ltd. For live market cap and broader valuation context, see how much is Standard Chemical & Pharmaceutical Co Lt worth.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.44x | NT$744.16 Million | NT$1.69 Billion | NT$599.61 Million | ▼ -31.8% |
| 2023 | 0.64x | NT$860.59 Million | NT$1.34 Billion | NT$625.70 Million | ▼ -39.0% |
| 2022 | 1.06x | NT$1.30 Billion | NT$1.23 Billion | NT$1.20 Billion | ▲ +104.3% |
| 2021 | 0.52x | NT$427.38 Million | NT$827.03 Million | NT$217.92 Million | ▼ -28.4% |
| 2020 | 0.72x | NT$665.56 Million | NT$922.58 Million | NT$352.49 Million | ▲ +73.5% |
| 2019 | 0.42x | NT$265.30 Million | NT$637.94 Million | NT$179.11 Million | ▲ +10.6% |
| 2018 | 0.38x | NT$182.32 Million | NT$484.94 Million | NT$169.36 Million | ▼ -31.9% |
| 2017 | 0.55x | NT$391.46 Million | NT$708.74 Million | NT$385.64 Million | ▼ -68.9% |
| 2016 | 1.78x | NT$542.75 Million | NT$305.38 Million | NT$177.92 Million | ▲ +442.0% |
| 2015 | 0.33x | NT$213.43 Million | NT$650.87 Million | NT$178.98 Million | ▼ -33.5% |
| 2014 | 0.49x | NT$287.29 Million | NT$582.30 Million | NT$177.53 Million | ▼ -64.5% |
| 2013 | 1.39x | NT$593.96 Million | NT$427.26 Million | NT$422.73 Million | ▲ +126.6% |
| 2012 | 0.61x | NT$246.76 Million | NT$402.25 Million | NT$246.76 Million | ▼ -16.7% |
| 2011 | 0.74x | NT$298.50 Million | NT$405.49 Million | NT$298.50 Million | ▼ -35.2% |
| 2010 | 1.14x | NT$309.66 Million | NT$272.47 Million | NT$309.66 Million | ▲ +170.8% |
| 2009 | 0.42x | NT$266.14 Million | NT$634.23 Million | NT$266.14 Million | ▲ +56.8% |
| 2008 | 0.27x | NT$192.50 Million | NT$719.17 Million | NT$192.50 Million | ▲ +19.1% |
| 2007 | 0.22x | NT$72.72 Million | NT$323.60 Million | NT$72.72 Million | ▼ -15.1% |
| 2006 | 0.26x | NT$95.01 Million | NT$358.75 Million | NT$95.01 Million | ▲ +93.4% |
| 2005 | 0.14x | NT$50.78 Million | NT$370.77 Million | NT$50.78 Million | ▲ +12.2% |
| 2004 | 0.12x | NT$40.95 Million | NT$335.45 Million | NT$40.95 Million | ▼ -77.8% |
| 2003 | 0.55x | NT$149.81 Million | NT$272.89 Million | NT$149.81 Million | ▼ -57.9% |
| 2002 | 1.30x | NT$192.54 Million | NT$147.75 Million | NT$192.54 Million | — |